PLX PROTALIX BIOTHERAPEUTICS INC Product Launches 8-K Filing 2023 - Product Launch Protalix BioTherapeutics and Chiesi Global Rare Diseases announced that PRX-102 has received marketing authorization in the EU for the treatment of Fabry disease.Get access to all SEC 8-K filings of the PROTALIX BIOTHERAPEUTICS INC